A desensitization of hypothalamic 5-HT(1A) receptors by repeated injections of paroxetine: Reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT(1A) receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1581-1590

  Li, Q ^a,b   Muma, N A ^a   Battaglia, G ^a   Van De Kar, L D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; OXYTOCIN; PAROXETINE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG PROTEIN BINDING; HORMONAL REGULATION; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SEROTONIN UPTAKE; TISSUE DISTRIBUTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENOCORTICOTROPIC HORMONE; ANIMALS; AUTORADIOGRAPHY; GTP-BINDING PROTEINS; HYPOTHALAMUS; MALE; OXYTOCIN; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN UPTAKE INHIBITORS;

EID: 0030967945     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. ADELL, A., CARCELLER, A. AND ARTIGAS, F.: In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60: 1673-1681, 1993.
2. 1A antagonists. Trends Neurosci. 19: 378-383, 1996.
3. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 73: 277-280, 1995.
4. 1C receptors induces oxytocin release in the male rat. Brain Res. 611: 330-332, 1993.
5. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 134: 1127-1131, 1994.
6. BERTIN, B., FREISSMUTH, M., BREYER, R. M., SCHÜTZ, W., STROSBERG, A. D. AND MARULLO, S.: Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein α-subunits. J. Biol. Chem. 267: 8200-8206, 1992.
7. BLIER, P. AND DE MONTIGNY, C.: Current advances and trends in the treatment depression. Trends Pharmacol. Sci. 15: 220-226, 1994.
8. BRILEY, M. AND MORET, C.: Neurobiological mechanisms involved in antidepressant therapies. Clin. Neuropharmacol. 16: 387-400, 1993.
9. 1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J. Biol. Chem. 270: 18691-18699, 1995.
10. 1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. J. Pharmacol. Exp. Ther. 277: 1259-1266, 1996.
11. COWEN, P. J., ANDERSON, I. M. AND GRAHAME-SMITH, D. G.: Neuroendocrine effects of azapirones. J. Clin. Psychopharmacol. 10: suppl., 21S-25S, 1990.
12. DEVANE, C. L.: Pharmacokinetics of the newer antidepressants: Clinical relevance. Am. J. Med. 97: suppl. 6A, 13S-23S, 1994.
13. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology (Berlin) 121: 1-26, 1995.
14. DUMAN, R. S., HENINGER, G. R. AND NESTLER, E. J.: Molecular psychiatry: Adaptations of receptor-coupled signal transduction pathways underlying stress-and drug-induced neural plasticity. J. Nerv. Ment. Dis. 182:692-700, 1994.
15. ERIKSSON, E., HEDBERG, M. A., ANDERSCH, B. AND SUNDBLAD, C.: The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12: 167-176, 1995.
16. 1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein. Cellular Signalling 3: 547-557, 1991.
17. 1A receptor antagonist. Behav. Brain Res. 73: 337-353, 1995.
18. 1A receptors in rat brain membranes. Eur. J. Pharmacol. Mol. Pharmacol. 288: 173-186, 1995.
19. 1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10: 16-27, 1996.
20. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4: 131-144, 1991.
21. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain Res. 73: 281-283, 1995.
22. HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., MYLECHARANE, E. J., SAXENA, P. R. AND HUMPHREY, P. P. A.: VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-204, 1994.
23. INNIS, R. B. AND AGHAJANIAN, G. K.: Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. Eur. J. Pharmacol. 143: 195-204, 1987.
24. B-induced hyperpolarization of rat dorsal raphe neurons. Brain Res. 459: 27-36, 1988.
25. A receptor-activated current in cultured rat suprachiasmatic neurones. J. Physiol. (Lond.) 478: 67-73, 1994.
26. KEIL, L. C., ROSELLA-DAMPMAN, L. M., EMMERT, S. E., CHEE, O. AND SUMMY-LONG, J. Y.: Enkephalin inhibition of angiotensin-stimulated release of oxytocin and vasopressin. Brain Res. 297: 329-336, 1984.
27. 1A receptor agonist. Naunyn Schmiedeberg's Arch. Pharmacol. 346: 121-126, 1992.
28. 1A receptor antagonist. Brain Res. 673: 217-225, 1995.
29. 1A receptors in the rat central nervous system. J. Comp. Neurol. 365: 289-305, 1996.
30. LANE, R., BALDWIN, D. AND PRESKORN, S.: The SSRIs: Advantages, disadvantages and differences. J. Psychopharmacol. 9: suppl., 163-178, 1995.
31. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedeberg's Arch. Pharmacol. 352: 141-148, 1995.
32. 1A receptors in vivo. Eur. J. Pharmacol. 240: 307-310, 1993.
33. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105: 415-120, 1991.
34. 1A agonist 8-OH-DPAT in male rats. Brain Res. 630: 148-156, 1993.
35. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol. Psychiatry 36: 300-308, 1994.
36. o proteins (Abstract). Soc. Neurosci. 22: 1326 (527.2)-1326, 1996a.
37. 1A agonist. J. Pharmacol. Exp. Ther. 279: 1035-1042, 1996b.
38. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J. Pharmacol. Exp. Ther. 271: 1246-1252, 1994.
39. MULHERON, J. G., CASANAS, S. J., ARTHUR, J. M., GARNOVSKAYA, M. N., GETTYS, T. W. AND RAYMOND, J. R.: Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J. Biol. Chem. 269: 12954-12962, 1994.
40. o in neuroblastoma x glioma hybrid cells: Independent regulation during cyclic AMP-induced differentiation. J. Neurochem. 55: 1890-1898, 1990.
41. NEMEROFF, C. B.: Paroxetine: An overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression. J. Clin. Psychopharmacol. 13: suppl. 2, 10S-17S, 1993.
42. o α-subunits in rat forebrain. Synapse 23: 246-257, 1996.
43. 1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat. Neuroendocrinology 56: 797-802, 1992.
44. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, Australia, 1986.
45. PAZOS, A. AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res. 346: 205-230, 1985.
46. 1A receptors in rat brain as assessed by neuroendocrine responses to 8-OH-DPAT stimulation (Abstract). Soc. Neurosci. Abstr. 20: 1994.
47. 1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat. Pharmacol. Biochem. Behav. 33: 329-334, 1989.
48. sα. Biochemistry 32: 11064-11073, 1993.
49. o proteins in dorsal raphe nucleus. Eur. J. Pharmacol. 265: 103-106, 1994.
50. 1B agonists: A comparative study with dorsal raphe neurons. Neuropharmacology 27: 707-715, 1988.
51. STEEL, R. G. D. AND TORRIE, J. H.: Principles and Procedures of Statistics with Special Reference to the Biological Sciences, McGraw-Hill, New York, 1960.
52. STERNWEIS, P. C. AND ROBINSHAW, J. D.: Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J. Biol. Chem. 259: 13806-13813, 1984.
53. 7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 63: 456-164, 1994.
54. VAN DE KAR, L. D.: Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci. Biobehav. Rev. 13: 237-246, 1989.
55. VAN DE KAR, L. D.: Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 31: 289-320, 1991.
56. VAN DE KAR, L. D. AND BROWNFIELD, M. S.: Serotonergic neurons and neuroendoerine function. NIPS 8: 202-207, 1993.
57. 1A antagonist WAY-100635 inhibits the 8-OH-DPAT induced increase in plasma ACTH, corticosterone and oxytocin but not prolactin (Abstract). Soc. Neurosci. Abstr. 22: 1326 (527.3)-1326, 1996.
58. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4: 347-352, 1989.
59. WONG, D. T., BYMASTER, F. P. AND ENGLEMAN, E. A.: Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 57: 411-441, 1995.
60. ZILLES, K.: The Cortex of the Rat, a Stercotaxic Atlas, Springer-Verlag, Berlin 1985.